Overview
- 26 inspections across 25 sites are on record.
- 16 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-03-14.
At a glance
Inspections
26
Sites
25
Observations
16
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Samsung Biologics Co., Ltd. | 14 Mar 2018 | Human Drugs | On file |
| Daewoong Pharmaceutical Co. Ltd. | 17 Nov 2017 | Human Drugs | On file |
| Biolab SRL | 4 Apr 2012 | ||
| Rottendorf Pharma Gmbh | 30 Mar 2012 | On file | |
| Gfm Gesellschaft Fuer Micronisierung Mbh | 15 Mar 2012 | On file |
Sites inspected
Samsung Biologics Co., Ltd.Yeonsu District, Korea (the Republic of)1 insp.
Daewoong Pharmaceutical Co. Ltd.Hwaseong, Korea (the Republic of)1 insp.
Biolab SRLQuistello, Mantova, Italy1 insp.
Rottendorf Pharma GmbhEnnigerloh, Germany1 insp.
Gfm Gesellschaft Fuer Micronisierung MbhBremen, Germany1 insp.
Co-investigators
Investigators who share inspections with this person.
Miguel A Martinez3 shared
Sixto M Mercado Rios3 shared
Peter C Chow3 shared
Thuy T Nguyen2 shared
Susan M Jackson2 shared
Viviana Matta1 shared
Raphael Brykman1 shared
Timothy J Pohlhaus1 shared
William A Fritsch1 shared
Steven B Hertz1 shared
Full investigator report
Get the verbatim findings behind Alicia M Mozzachio's 16 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site